Glenmark Pharma Q2 Results : Co posts Rs 355 crore net profit on robust sales (...)
Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.
Site référencé: The Economic Times
The Economic Times
Olectra Greentech Q1 Results : PAT rises 7% YoY to Rs 26 crore, revenue surges nearly 11%
10/08/2025
Technocraft Ventures files IPO papers with Sebi, to raise funds via public issue
9/08/2025
F&O Talk| Nifty continues downward path, technical indicators show persistent weakness : Sudeep Shah
9/08/2025
Weigh in on Sydney Sweeney or run the world ? Trump, for better or worse, attempts it all
9/08/2025
Hybrid mutual funds see surge in AUM ; arbitrage and multi asset allocation lead growth : Ventura
9/08/2025
Parag Parikh Flexi Cap Fund increases stake in ITC and 11 other stocks in July
9/08/2025
